Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × gallium citrate × Clear all
NCT02391025 2023-06-18

Gallium-68 Citrate PET Used in Prostate Cancer

University of California, San Francisco

Phase EARLY_PHASE1 Completed
39 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02776891 2019-10-10

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

University of California, San Francisco

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00477503 2012-08-01

Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

M.D. Anderson Cancer Center

Phase 1 Terminated
1 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡